Centre for Ocular Research and Education
Waterloo, Ontario, N2L 3G1, Canada
NCT Number: NCT05617794
The objective of the study is to measure the effect of Diffusion Optics Technology (DOT) spectacle lenses on the choroidal thickness and choroidal vascularity index compared to control lenses.
This study is active but is not currently recruiting participants.
8 year–14 year
All sexes
Interventional
Not applicable
Waterloo, Ontario, N2L 3G1, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
DOT Pattern Spectacle Lens
Control Spectacles
Time frame: 30 minutes and 60 minutes
Change from Baseline, 30 minutes and 60 minutes
Time frame: 30 minutes and 60 minutes
Change from Baseline, 30 minutes and 60 minutes
Time frame: 30 minutes and 60 minutes
Comparison of measurements using different software methods; manual, semiautomated and automated software
SightGlass Vision, Inc.
Industry
Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness and Choroidal Vascularity Index in Emmetropes
Acronym: ASH-2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05650190
Eye Diseases, Juvenile Myopia
Longwood, Florida, United States
View Trial DetailsNCT05893979
Eye Diseases, Juvenile Myopia
Whittier, California, United States
View Trial DetailsNCT07229365
Eye Diseases, Juvenile Myopia
Bloomington, Indiana, United States
View Trial DetailsNCT07229352
Eye Diseases, Juvenile Myopia
Glendale, Arizona, United States
View Trial Details